deListed Australia
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


ASX Announcements (courtesy of ASX)


ASX, Legal & CGT Status


(updated at weekends)
2005 2006 2007   ALL
Former (or subsequent) names


Shareholder links


Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details
Address: Level 3 , 390 St Kilda Road , MELBOURNE , VIC, AUSTRALIA, 3004
Tel:  61 3 9868 0700 Fax: 61 3 9868 0166

Date first listed: 21/11/2005

Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Research and development, manufacture, marketing and distribution of injectable generic and specialty pharmaceuticals

many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service


delisted at the request of the Company, under listing rule 17.11


we understand Hospira was successful with an offer of $4.10 per Mayne Pharma share


securities suspended from quotation following lodgement of the court orders with ASIC in relation to the scheme of arrangement whereby all the Company's shares will be acquired by Hospira Inc


we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - Mayne Pharma shareholders will receive $4.10 cash under scheme with Hospira Inc - this corporate event may appear elsewhere in this company record


Mayne Group Limited (Mayne) undertook a number of transactions to separate the ownership of the international pharmaceutical business (to Mayne Pharma and its subsidiaries) - Mayne (now Symbion Health Limited) retained the domestic healthcare businesses - as a result of the demerger, Mayne shareholders held shares in both Symbion Health and Mayne Pharma - the demerger was undertaken via a Scheme of Arrangement whereby Mayne undertook a capital reduction under which a total of approximately $1.56 billion of contributed capital was returned to Mayne shareholders (capital reduction amount) - this amounted to approximately $2.45 per ordinary issued Mayne share - the capital reduction amount was applied on behalf of Mayne shareholders for the subscription of approximately 636 million new shares in Mayne Pharma - Mayne shareholders subscribed for one new Mayne Pharma share for every one Mayne share they held before the demerger and Mayne Pharma used the funds received on the issue of the new shares to repay outstanding loans to Mayne

View ASX Announcements (courtesy of ASX)


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.


Company Updates
Post your comments here
Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    06/12/2005Nora ScheinkestelOn market4,100$2.470$10,127
    06/12/2005John SimeOn market10,000$2.520$25,200
    29/11/2005Nora ScheinkestelOn market11,746$2.690$31,597
    08/11/2005Stuart JamesOn market93,876$5.400$506,930
    14/10/2005Nora ScheinkestelOn market7,590$5.250$39,848

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    Peter WilcoxChairman04/10/2005
    Thierry SoursacManaging Director, CEO18/11/2005
    Rowan RussellDirector04/10/2005
    Nora ScheinkestelDirector04/10/2005
    John SimeDirector04/10/2005
    Tamara JosephGeneral Counsel
    Tamara Lynn JosephCompany Secretary
    D.C. KiriacoulacosCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    Paul McClintockChairman08/06/200518/11/2005
    Stuart JamesManaging Director, CEO15/08/200418/11/2005
    Ian BlackburneNon Exec Director01/09/200418/11/2005
    James HallNon Exec Director08/06/200518/11/2005
    Paul BinfieldDirector18/11/200518/11/2005

    Date of first appointment, title may have changed.